321 related articles for article (PubMed ID: 33416109)
1. MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4.
Zheng Y; Liu Y; Wang L; Xu H; Lu Z; Xuan Y; Meng W; Ye L; Fang D; Zhou Y; Ke K; Liu Y; An M
Int J Mol Med; 2021 Jan; 47(1):151-160. PubMed ID: 33416109
[TBL] [Abstract][Full Text] [Related]
2. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
3. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
4. Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.
Gong Q; Xie J; Liu Y; Li Y; Su G
J Diabetes Res; 2017; 2017():4727942. PubMed ID: 28706953
[TBL] [Abstract][Full Text] [Related]
5. Low expression of microRNA-15b promotes the proliferation of retinal capillary endothelial cells and pericytes by up-regulating VEGFA in diabetic rats.
Xu Y; Xie SC; Ma YC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6018-6025. PubMed ID: 31364104
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
7. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.
Cao YL; Liu DJ; Zhang HG
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4427-4430. PubMed ID: 30058674
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
10. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway.
Xue L; Xiong C; Li J; Ren Y; Zhang L; Jiao K; Chen C; Ding P
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33150936
[TBL] [Abstract][Full Text] [Related]
11. The expression and significance of mTORC1 in diabetic retinopathy.
Liu Y; Zheng Y; Zhou Y; Liu Y; Xie M; Meng W; An M
BMC Ophthalmol; 2020 Jul; 20(1):297. PubMed ID: 32689970
[TBL] [Abstract][Full Text] [Related]
12. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
[TBL] [Abstract][Full Text] [Related]
13. Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
Liu TT; Hao Q; Zhang Y; Li ZH; Cui ZH; Yang W
Acta Ophthalmol; 2018 Aug; 96(5):e626-e635. PubMed ID: 29488353
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway.
Sun Y; Liu YX
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2941-2948. PubMed ID: 29863235
[TBL] [Abstract][Full Text] [Related]
15. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
[TBL] [Abstract][Full Text] [Related]
16. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
Chen J; Sun Y; Chen L; Zhou Y
Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
[TBL] [Abstract][Full Text] [Related]
17. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
18. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
20. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
